Mortgage and insurance company Essent's Q3 net income falls

Reuters
11/07
Mortgage and insurance company Essent's Q3 net income falls

Overview

  • Essent Q3 net income at $164.2 mln, down from $176.2 mln in 2024

  • Insurance in force rises to $248.8 bln, up from $243.0 bln last year

  • In Nov, Essent announced $500 mln share repurchase authorization through 2027

Outlook

  • Essent Group did not provide specific guidance for future quarters or full year

Result Drivers

  • CREDIT TRENDS - Co attributes Q3 performance to favorable credit trends and interest rate environment, enhancing portfolio persistency and investment income

  • INSURANCE IN FORCE - Insurance in force increased to $248.8 bln from $246.8 bln in the previous quarter and $243.0 bln last year

  • NEW INSURANCE WRITTEN - New insurance written decreased to $12.2 bln from $12.5 bln in Q2 2025 and Q3 2024

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Direct Premiums Written

$280.80 mln

Q3 Net Income

$164.22 mln

Q3 Pretax Profit

$199.16 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the property & casualty insurance peer group is "buy"

  • Wall Street's median 12-month price target for Essent Group Ltd is $67.50, about 10% above its November 6 closing price of $60.78

  • The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release: ID:nGNXbn9ZrH

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10